Peripheral nerve functions may deteriorate parallel to the progression of microangiopathy in diabetic patients

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 16, Issue 5, 2006, Pages 313-321

  Ogawa, Kenichi ^a   Sasaki, Hideyuki ^a   Yamasaki, Hiroshi ^a   Okamoto, Kunihisa ^a   Matsuno, Shohei ^a   Shono, Takeshi ^a   Doi, Takuya ^a   Arimoto, Keiko ^a   Furuta, Hiroto ^a   Nishi, Masahiro ^a   Nakao, Taisei ^a   Nanjo, Kishio ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Diabetic foot ulcer; Diabetic polyneuropathy; Microangiopathy; Progression pattern; QSART (quantitative sudomotor axon reflex test)

Indexed keywords

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROLOGIC EXAMINATION; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVE; PHYSIOLOGY;

ADULT; AUTONOMIC NERVOUS SYSTEM; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROLOGIC EXAMINATION; PERIPHERAL NERVES; SEVERITY OF ILLNESS INDEX;

EID: 33745635732     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2005.06.003     Document Type: Article

References (26)

1. Thomas P.K. Classification, differential diagnosis, and staging of diabetic peripheral neuropathy. Diabetes 46 (1997) S54-S57
2. Jude E.B., and Boulton A.J.M. End-stage complications of diabetic neuropathy. Diabetes Rev 7 (1999) 395-410
3. Maser R.E., Mitchell B.D., Vinik A.I., and Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 26 (2003) 1895-1901
4. Giannini C., and Dyck P.J. Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity. Ann Neurol 37 (1995) 498-504
5. Malik R.A., Newrick P.G., Sharma A.K., Jennings A., Ah-See A.K., Mayhew T.M., et al. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 32 (1989) 92-102
6. Low P.A., Denq J.C., Opfer-Gehrking T.L., Dyck P.J., O'Brien P.C., and Slezak J.M. Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects. Muscle Nerve 20 (1997) 1561-1568
7. Low P.A., Caskey P.E., Tuck R.R., Fealey R.D., and Dyck P.J. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol 14 (1983) 573-580
8. Sasaki H., Nanjo K., Yamada M., Naka K., Bissho H., Kikuoka H., et al. Diabetic neuropathy as a heterogeneous syndrome: multivariate analysis of clinical and neurological findings. Diabetes Res Clin Pract 4 (1988) 215-222
9. Sasaki H., Yamada M., Naka K., Kishi Y., Satogami E., Kondo M., et al. An attempt for objective, quantitative evaluation of the severity of diabetic neuropathy. In: Mimura G., and Zhisheng C. (Eds). Recent trends of diabetes mellitus in East Asia (ICS 908) (1990), Elsevier 227-230
10. American Autonomic Society and American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin Auton Res 6 (1996) 125-126
11. Low P.A., and Fealey R.D. Sudomotor neuropathy. In: Thomas P.K., and Dyck P.J. (Eds). Diabetic neuropathy. 2nd ed. (1999), W.B. Saunders 191-199
12. Dyck P.J., Davies J.L., Wilson D.M., Service F.J., Melton L.J., and O'Brien P.C. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the rochester diabetic neuropathy study cohort. Diabetes Care 22 (1999) 1479-1486
13. Vinik A.I., Erbas T., Park T.S., Stansberry K.B., Scanelli J.A., and Pittenger G.L. Dermal neurovascular dysfunction in type 2 diabetes. Diabetes Care 24 (2001) 1468-1475
14. Smith A.G., Ramachandran P., Tripp S., and Singleton J.R. Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 13 (2001) 1701-1704
15. Sumner C.J., Sheth S., Griffin J.W., Cornblath D.R., and Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 14 (2003) 108-111
16. Cherian P.V., Kamijo M., Angelides K.J., and Sima A.A. Nodal Na(+)-channel displacement is associated with nerve-conduction slowing in the chronically diabetic BB/W rat: prevention by aldose reductase inhibition. J Diabetes Complicat 10 (1996) 192-200
17. Waxman S.G. Voltage-gated ion channels in axons: localization, function, and development. In: Waxman S.G., Kocsis J.D., and Stys P.K. (Eds). The axon: structure, function and pathophysiology (1995), Oxford Press, NY, New York 218-243
18. Yang Q., Kaji R., Takagi T., Kohara N., Murase N., Yamada Y., et al. Abnormal axonal inward rectifier in streptozocin-induced experimental diabetic neuropathy. Brain 124 (2001) 1149-1155
19. Mulder D.W., Lambert E.H., Bastron J.A., and Sprague R.G. The neuropathies associated with diabetes mellitus. A clinical and electromyographic study of 103 unselected diabetic patients. Neurology 11 (1961) 275-284
20. Kohara N., Kimura J., Kaji R., Goto Y., Ishii J., Takiguchi M., et al. F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicentre analysis in healthy subjects and patients with diabetic polyneuropathy. Diabetologia 43 (2000) 915-924
21. Veves A., Malik R.A., Lye R.H., Masson E.A., Sharma A.K., Schady W., et al. The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy. Diabetes Med 8 (1991) 917-921
22. Hoeldtke R.D., Bryner K.D., Horvath G.G., Phares R.W., Broy L.F., and Fobbs G.R. Redistribution of sudomotor responses is an early sign of sympathetic dysfunction in type 1 diabetes. Diabetes Care 50 (2001) 436-443
23. Levin M.E. Diabetic foot ulcers: pathogenesis and management. J ET Nurs 20 (1993) 191-198
24. Pham H., Armstrong D.G., Harvey C., Hairless L.B., Giurini J.M., and Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care 23 (2000) 606-611
25. Young M.J., Breddy J.L., Veves A., and Boulton A.J. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds, a prospective study. Diabetes Care 17 (1994) 557-560
26. Carrington A.L., Shaw J.E., Van Schie C.H., Abbott C.A., Vileikyte L., and Boulton A.J. Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period?. Diabetes Care 25 (2002) 2010-2015